Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Zifo Co-Launches REAL 2026 to Spotlight the Next Generation of Connected, AI-Enabled Lab Environments

This image opens in the lightbox

News provided by

Zifo

10 Sep, 2026, 12:30 GMT

Share this article

Share toX

Share this article

Share toX

REAL 2026 is designed as a curated, invite-only event for senior leaders across pharma, biotech, automation, data, and AI 

CAMBRIDGE, Mass. and CAMBRIDGE, England, Sept. 10, 2026 /PRNewswire/ -- As physical AI and agentic platforms rapidly reshape biopharma R&D and accelerate the convergence of robotics, scientific data, analytics, and AI, Zifo today announced the launch of REAL 2026: Readiness & Enablement for Automated Labs, an industry summit dedicated to advancing the next generation of connected, AI-enabled lab environments.

Continue Reading
This image opens in the lightbox
Margaret Difilippo, Zifo’s Head of Commercial in North America, brings 35 years of Biopharma experience to address next generation of connected, AI-enabled lab environments.

Taking place on September 15, 2026, at Boston's Seaport District, REAL 2026 will bring together leaders from pharma, biotech, automation, data, and AI to explore what it will take to realize the industry's vision of a fully integrated 'lab-in-the-loop' environment. By fostering candid discussions between the organizations developing these technologies and those deploying them in real-world research settings, the summit aims to accelerate collective learning around the data, infrastructure, operating models, and collaboration needed to make automated laboratories a practical reality.

Margaret DiFilippo, Zifo's Head of Commercial in North America, stated: "The future of lab innovation will depend on more than automation alone. Real progress requires bringing together scientists, automation experts, data leaders, and AI practitioners to address the technical, operational, and organizational challenges of creating truly connected laboratories. We are proud to announce the launch of REAL 2026 and contribute to these important industry conversations."

Industry Perspectives from Across the Automated Lab Ecosystem

REAL 2026 will feature leaders who are actively building, operating, and scaling automated laboratory environments. The program is designed to combine strategic perspectives with practical implementation experiences, creating an opportunity for attendees to learn from organizations working across the automation stack.

Featured speakers include leaders from companies such as Novo Nordisk, Merck, Pacific Northwest National Laboratory (PNNL), Lila Sciences, TetraScience, Benchling, Dotmatics, HighRes, and Automata, representing diverse perspectives across the evolving automated laboratory ecosystem.

The agenda includes:

  • The Autonomous Wet Lab of the Future
    • Jason Kelly
  • Unlocking Next Gen Translational Bioanalytics for Vaccine Studies for Preclinical and Clinical Studies
    • Xinnian Li, Principal Scientist Leading Autonomous Robotic Orchestration, Merck and Carol Rohl, Associate Vice President, Global Research IT and Informatics at Merck
  • Building the Digital Ecosystem for the Lab of the Future — From Data Chaos to AI-Ready Infrastructure
    • Nevin Gerek, Director, Digital Labs, Research Digital Products, Novo Nordisk
  • A National Lab Perspective: A Real Implementation Story
    • Todd Edwards, Chief Technology Integration Officer, Environmental Molecular Sciences, PNNL
  • Market View: What We Are Seeing Across the Industry
    • Zifo (Organization-led session) A 25-minute view from the front lines of the market, plus live Q&A on where the puck is headed next.
  • Hardware Innovator Lightning Talks (Rapid-fire talks on what's possible today and what's on the roadmap from the teams building the physical layer of automated labs)
    • Tom Rawlins, VP, Marketing, HighRes
    • Bohui Li, Ph.D., Product Manager, Lab Automation Solutions, XtalPi
    • Chirag Patel, Head of Sales, Automata
  • Software & Data Infrastructure Lightning Talks (Rapid-fire talks from the other half of the stack — the platforms turning lab data into usable intelligence)
    • Michael Hopkins, Product Management, Lab Automation, Benchling
    • Darren Pittman, Principal Lab Orchestration Architect, Dotmatics
    • Matt Studney, Chief Customer Officer, TetraScience
  • Scaling the Scientific Method: Frontier AI & Autonomous Labs on the Path to Superintelligence
    • Ryan Leung, Vice President, Head of Life Sciences, LILA
  • Closing Panel: What Will It Actually Take to Make It REAL?
    • Moderated by Stacie Calad-Thomson, PhD, Global Business Development Lead, Pharma Labs and Manufacturing at NVIDIA

Advancing Readiness and Enablement for Automated Labs

As labs generate growing volumes of scientific data and organizations pursue new levels of automation, the need for integrated, interoperable, and scalable research environments continues to increase. REAL 2026 aims to help the industry navigate that transition by fostering collaboration among organizations developing automation technologies and those deploying them within scientific environments.

For Zifo this event reflects a continued commitment to helping science-driven organizations connect laboratory processes, scientific data, informatics platforms, and AI capabilities to optimize discovery and improve decision-making. By bringing together experts from across the ecosystem, REAL 2026 seeks to advance the readiness and enablement needed to move automated laboratories from aspiration to reality.

REAL 2026 is designed as a curated event for senior leaders across pharma, biotech, automation, data, and AI. To encourage the candid discussions that are central to the summit's mission, most sessions will not be recorded; however, a written recap will be shared with attendees. Participation is by invitation, and interested attendees can request an invitation through the event registration page. https://real-summit.org/; https://zifo.com/event/real-2026-readiness-enablement-for-automated-labs/

About REAL 2026

REAL 2026 (Readiness & Enablement for Automated Labs) is a one-day summit taking place on September 15, 2026, in Boston's Seaport District. The event brings together leaders across biopharma, biotechnology, laboratory automation, data infrastructure, and AI to accelerate learning and collaboration around the future of automated laboratories. https://real-summit.org/; https://zifo.com/event/real-2026-readiness-enablement-for-automated-labs/

About Zifo

Zifo is the leading global enabler of AI and data driven enterprise informatics for science driven organizations. With extensive solutions and services expertise spanning research, development, manufacturing, and clinical domains, we serve a diverse range of industries, including Pharma, Biotech, Chemicals, Food and Beverage, Oil & Gas, and FMCG. Trusted by over 190 science-focused organizations worldwide, Zifo is the partner of choice for advancing digital scientific innovation. https://zifo.com/

Modal title

Also from this source

CMC Bottleneck is Choking Biopharma's Drug Pipeline, says Zifo

CMC Bottleneck is Choking Biopharma's Drug Pipeline, says Zifo

The biopharma industry has invested heavily in accelerating discovery. AI, machine learning (ML), high-throughput experimentation and advanced...

Zifo Accelerates LIMS Master Data Validation with New AI-Enabled Services Accelerator

Zifo Accelerates LIMS Master Data Validation with New AI-Enabled Services Accelerator

Zifo, a leading global enabler of AI and data-driven enterprise informatics for science-driven organizations, today announced the launch of its new...

More Releases From This Source

Explore

Biotechnology

Biotechnology

STEM (Science, Tech, Engineering, Math)

STEM (Science, Tech, Engineering, Math)

Artificial Intelligence

Artificial Intelligence

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.